| COMPOSITION: | Each uncoated mouth dissolving tablet contains Prochlorperazine Maleate 5 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Vomiford contains Prochlorperazine Maleate which works by blocking D2 dopamine receptors in a specific area of the brain called the chemoreceptor trigger zone (CTZ), thus prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. |
| SIDE EFFECTS: | Common side effects are headache, constipation, weakness, tiredness, chills and drowsiness. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
